Background: We aimed to review and analyse the effectiveness and safety of botulinum
toxin type A (BoNT-A) injections for drooling in children with cerebral palsy. Data sources …

Introduction and objectives In recent years, Botulinum Toxin has been shown to be
efficacious and safe in the treatment of sialorrhea, but scanty data are available on its long …

Objectives The aim of this study is to evaluate the correlation of the Drooling Quotient (DQ)
score with the questionnaire-based Drooling Severity and Frequency Scale (DSFS) and the …

Paediatric anterior drooling has a major impact on the daily lives of children and caregivers.
Intraglandular botulinum neurotoxin type-A (BoNT-A) injections are considered an effective …

Infants with neurological injury and their families face unique challenges in the neonatal
intensive care unit. As specialty palliative care support becomes increasingly available, we …

Aim The aims of this study were:(1) to determine the incidence and nature of adverse effects
on oral motor function after first injections of botulinum neurotoxin A (Bo NT‐A) in …

Aims: We aimed to evaluate the effectivity and safety of botulinum toxin A (BT-A) to reduce
sialorrhea in children with hypersalivation due to neurological diseases. Methods: Patients …

Objectives/Hypothesis Onabotulinum toxin A (OBTXA) injection is a well‐established
therapeutic option for the management of drooling. Many of the children treated undertake …

Background: Drooling is the unintentional loss of saliva from the mouth, usually caused by
poor coordination of the swallowing mechanism. It is commonly seen in patients with chronic …

Objective To determine the effectiveness of submandibular salivary gland Botulinum Toxin
Type-A (BTX-A) injection in the treatment of drooling in children with varying degrees of …